NEWS

We Work For Health released the following statement on the Trump Administration’s April 15 executive order regarding the Inflation...

Small-molecule drug investment has fallen 68%—and 74% for diseases mainly affecting Medicare patients—since the IRA was introduced FOR...

The lead sponsors of the Ensuring Pathways to Innovative Cures (EPIC) Act addressed a room full of Congressional office employees and...

Learn about the Inflation Reduction Act—and how it’s threatening America’s biopharmaceutical ecosystem and our nation’s Medicare-aged...

Innovation often comes in increments. The first smartphones could not record video or take front-facing photos, and there certainly was...

A new report highlights the significant investments and economic impact generated by clinical trials funded by the biopharmaceutical...

Legislation would address the “pill penalty” and strengthen U.S. leadership in pharmaceutical innovation. WASHINGTON, D.C. (March 6,...

Healthcare costs continue to be a significant concern for Americans. While policies like government price controls under the Inflation...